» Articles » PMID: 26594620

Measuring Longitudinal Myelin Water Fraction in New Multiple Sclerosis Lesions

Overview
Journal Neuroimage Clin
Publisher Elsevier
Specialties Neurology
Radiology
Date 2015 Nov 24
PMID 26594620
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Investigating the potential of myelin repair strategies in multiple sclerosis (MS) requires an understanding of myelin dynamics during lesion evolution. The objective of this study is to longitudinally measure myelin water fraction (MWF), an MRI biomarker of myelin, in new MS lesions and to identify factors that influence their subsequent myelin content.

Methods: Twenty-three MS patients were scanned with whole-brain Fast Acquisition with Spiral Trajectory and T2prep (FAST-T2) MWF mapping at baseline and median follow-up of 6 months. Eleven healthy controls (HC) confirmed the reproducibility of FAST-T2 in white matter regions of interests (ROIs) similar to a lesion size. A random-effect-model was implemented to determine the association between baseline clinical and lesion variables and the subsequent MWF.

Results: ROI-based measurements in HCs were highly correlated between scans [mean r = 0.893 (.764-.967)]. In MS patients, 38 gadolinium enhancing (Gd+) and 25 new non-enhancing (Gd-) T2 hyperintense lesions (5.7 months, ±3.8) were identified. Significant improvement in MWF was seen in Gd+ lesions (0.035 ± 0.029, p < 0.001) as compared to Gd- lesions (0.006 ± 0.017, p = 0.065). In the model, a higher baseline MWF (p < 0.001) and the presence of Gd (p < 0.001) were associated with higher subsequent MWF.

Conclusions: FAST T2 provides a clinically feasible method to quantify MWF in new MS lesions. The observed influence of baseline MWF, which represents a combined effect of both resolving edema and myelin change within acute lesions, suggests that the extent of initial inflammation impacts final myelin recovery.

Citing Articles

Advanced MRI Measures of Myelin and Axon Volume Identify Repair in Multiple Sclerosis.

Sanabria-Diaz G, Cagol A, Lu P, Barakovic M, Ocampo-Pineda M, Chen X Ann Neurol. 2024; .

PMID: 39390658 PMC: 11683175. DOI: 10.1002/ana.27102.


Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions.

Muller J, Lu P, Cagol A, Ruberte E, Shin H, Ocampo-Pineda M Neurology. 2024; 103(6):e209604.

PMID: 39213476 PMC: 11362958. DOI: 10.1212/WNL.0000000000209604.


Bioavailable central nervous system disease-modifying therapies for multiple sclerosis.

Hartung H, Cree B, Barnett M, Meuth S, Bar-Or A, Steinman L Front Immunol. 2024; 14:1290666.

PMID: 38162670 PMC: 10755740. DOI: 10.3389/fimmu.2023.1290666.


Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging.

Gloor M, Andelova M, Gaetano L, Papadopoulou A, Villena F, Sprenger T Eur Radiol. 2023; 34(3):1680-1691.

PMID: 37658894 PMC: 10873225. DOI: 10.1007/s00330-023-10173-6.


Use of gadolinium-based contrast agents in multiple sclerosis: a review by the ESMRMB-GREC and ESNR Multiple Sclerosis Working Group.

Rovira A, Doniselli F, Auger C, Haider L, Hodel J, Severino M Eur Radiol. 2023; 34(3):1726-1735.

PMID: 37658891 DOI: 10.1007/s00330-023-10151-y.


References
1.
Vavasour I, Laule C, Li D, Oger J, Moore G, Traboulsee A . Longitudinal changes in myelin water fraction in two MS patients with active disease. J Neurol Sci. 2008; 276(1-2):49-53. DOI: 10.1016/j.jns.2008.08.022. View

2.
Deoni S, Rutt B, Arun T, Pierpaoli C, Jones D . Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn Reson Med. 2008; 60(6):1372-87. DOI: 10.1002/mrm.21704. View

3.
Greve D, Fischl B . Accurate and robust brain image alignment using boundary-based registration. Neuroimage. 2009; 48(1):63-72. PMC: 2733527. DOI: 10.1016/j.neuroimage.2009.06.060. View

4.
Meyers S, Laule C, Vavasour I, Kolind S, Madler B, Tam R . Reproducibility of myelin water fraction analysis: a comparison of region of interest and voxel-based analysis methods. Magn Reson Imaging. 2009; 27(8):1096-103. DOI: 10.1016/j.mri.2009.02.001. View

5.
Fancy S, Kotter M, Harrington E, Huang J, Zhao C, Rowitch D . Overcoming remyelination failure in multiple sclerosis and other myelin disorders. Exp Neurol. 2010; 225(1):18-23. DOI: 10.1016/j.expneurol.2009.12.020. View